Medicine and Dentistry
Antagonist
100%
Atypical Antipsychotic
75%
Effusion
75%
Lurasidone
75%
Cognitive Defect
50%
Dopamine
50%
Dorsal Striatum
50%
Aptitude
50%
Neurotransmitter
37%
Acetylcholine
37%
Clozapine
25%
Brain Areas
25%
Medial Prefrontal Cortex
25%
Dopamine 4 Receptor
25%
Recognition
25%
Receptor
12%
Systemic Administration
12%
Stimulation
12%
Cognition
12%
Receptor Antagonist
12%
Phencyclidine
12%
Dopamine Release
12%
Risperidone
12%
Pharmacology, Toxicology and Pharmaceutical Science
Atypical Antipsychotics
75%
Effusion
75%
Agonist
75%
Lurasidone
75%
Schizophrenia
62%
Dopamine
50%
Cognitive Defect
50%
Acetylcholine
37%
Clozapine
25%
Dopamine 4 Receptor
25%
Rat
25%
Receptor
12%
Receptor Antagonist
12%
Phencyclidine
12%
Risperidone
12%
Systemic Administration
12%
Microdialysis
12%
Mouse
12%
Neuroscience
Atypical Antipsychotic
75%
Lurasidone
75%
Dementia Praecox
62%
Dopamine
50%
Cognitive Disorders
50%
Acetylcholine
37%
Agonist
37%
Clozapine
25%
Prefrontal Cortex
25%
Dopamine Receptor D4
25%
Recognition
25%
In Vivo
12%
Eicosanoid Receptor
12%
Receptor Antagonist
12%
Phencyclidine
12%
Dopamine Release
12%
Risperidone
12%
Microdialysis
12%
Cognition
12%
INIS
dopamine
87%
drugs
75%
receptors
50%
acetylcholine
37%
effective doses
37%
rats
25%
mice
12%
rodents
12%
levels
12%
in vivo
12%
stimulation
12%
brain
12%
administration
12%
augmentation
12%